Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 367514-87-2 | Product Number: L0280
Lurasidone
×
![]()
×
Purity: >98.0%(HPLC)(N)
Synonyms:
- (3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
Product Documents:
| Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
|---|---|---|---|---|---|
| 250MG |
$80.00
|
Contact Us | Contact Us | 27 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | L0280 |
| Purity / Analysis Method | >98.0%(HPLC)(N) |
| Molecular Formula / Molecular Weight | C__2__8H__3__6N__4O__2S = 492.68 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Heat Sensitive |
| CAS RN | 367514-87-2 |
| PubChem Substance ID | 468592140 |
| MDL Number | MFCD14635357 |
Specifications
| Appearance | White to Orange to Green powder to crystaline |
| Purity(HPLC) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 98.0 % |
| Melting point | 147.0 to 151.0 °C |
| Specific rotation [a]20/D | -20.0 to -24.0 deg(C=0.5, methanol) |
Properties (reference)
| Melting Point | 149 °C |
| Solubility in water | Insoluble |
| Degree of solubility in water | 0.0532 mg/l 25 °C |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H317 : May cause an allergic skin reaction. H351 : Suspected of causing cancer. H413 : May cause long lasting harmful effects to aquatic life. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P273 : Avoid release to the environment. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P272 : Contaminated work clothing must not be allowed out of the workplace. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P302 + P352 : IF ON SKIN: Wash with plenty of soap and water. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. P363 : Wash contaminated clothing before reuse. P405 : Store locked up. |
Related Laws:
Transport Information:
| HS Number | 2934.20.8000 |
Application
Lurasidone: An Atypical Antipsychotic Agent with the Effects of Antagonizing D2 and 5-HT2A Receptors
Lurasidone (SM-13496) is an azapirone derivative and an atypical antipsychotic agent in development for the treatment of schizophrenia and bipolar depression. In vitro studies has suggested that lurasidone is an antagonist with high affinity for dopamine D2 receptors and serotonin 5-HT2A and 5-HT7 receptors. It also binds with moderate affinity to the human α2C adrenergic receptors to, is a partial agonist at serotonin 5-HT1A receptors, and is an antagonist at the α2A adrenergic receptors. Meanwhile, lurasidone exhibits little or no affinity for histamine H1 and muscarinic M1 receptors. The precise pharmacological mechanism of action of lurasidone is unknown, but lurasidone is believed to show the psychotropic effect through a combination of D2 and 5-HT2A receptor antagonism. (The product is for research purpose only.)
References
- Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7(5-HT7) and 5-HT1A receptor activity
- The preclinical profile of lurasidone: clinical relevance for the treatment of schizophrenia (a review)
- Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high-performance liquid chromatography with tandem mass spectrometry
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.